Community Health sees 44% drop in first-half operating income
Despite the decrease, Community Health Network saw an increase in admissions, emergency visits, deliveries and physician outpatient visits during the first six months of 2024.
John Russell
Articles
How Lilly wooed Massachusetts biotech with flurry of offers
It was a mating dance that lasted more than three years. At the end, Eli Lilly and Co. wound up buying a Massachusetts-based biotech developing treatments for inflammatory bowel disease for $3.2 billion.
IU Health’s massive hospital project is on schedule, should ‘top out’ next spring
Work on Indiana University Health’s $4.3 billion downtown hospital campus, one of the most expensive construction projects in Indiana history, is set to be finished in late 2027.
Lilly shares slide 7% after Roche announces obesity pill test results
The Roche drug is a once-daily pill, compared to Lilly’s tirzepatide, sold under the brand names Mounjaro (for diabetes) and Zepbound (for obesity), which is a once-weekly shot.
Pharmacy software company lays off 71, including 11 at Indy HQ
Just three years ago, Indianapolis-based Innovation Associates had huge hopes for growth here. But instead of growing, the company is now shrinking. Last week, the company quietly laid off 11 people in the Indy office and 60 people in other markets.
INCOG BioPharma investing additional $125M on Fishers campus
The expansion plan includes construction of a 100,000-square-foot building on its corporate campus and the addition of 100 jobs.
State utility counselor urges regulators to slash Duke Energy’s rate hike request
Duke Energy Indiana, the state’s largest electric utility, in April filed a request with state regulators for permission to raise rates by about 16% over two years.
Labor Department wants Indy health care owner held in contempt on overtime issues
The Labor Department filed a complaint this week in U.S. District Court against the owner of eight Indianapolis-area health care services companies, saying an estimated 700 employees might have been shortchanged by his practices.
Elanco completes $1.3B sale of aqua business, allowing it to reduce debt load
The company had debt of $5.7 billion as of March 31 and has been under pressure from Wall Street to reduce it.
Chemo drug cisplatin increases risk of long-term hearing loss, IU researchers find
The study followed a group of testicular cancer survivors for an average of 14 years, revealing that 78% experience significant difficulties in everyday listening situations.
Lilly to buy Massachusetts biopharma company for $3.2B
Massachusetts-based Morphic Holding Inc. is a nine-year old, publicly traded company that is developing a class of drugs known as oral integrin therapies to treat autoimmune diseases, pulmonary hypertensive diseases, fibrotic diseases and cancer.
Franciscan Alliance sued by Indy physician for breach of contract, interfering in practice
Dr. Greg Hardin, an orthopedic surgeon who specializes in sports medicine, claims that Franciscan Alliance engaged in conduct harmful to his practice over the course of several years.
Hamilton County hospital surge comes amid closings elsewhere
Community Health Network’s announcement this month that it plans to open a $335 million campus near U.S. 31 and 196th Street in Westfield marks the latest entry into the crowded Hamilton County hospital market.
Lilly files suit against more spas, weight-loss centers selling knockoff version of its popular drugs
The Indianapolis-based drugmaker said Thursday it was taking legal action against at least six additional medical spas and weight loss centers that it claimed are selling counterfeit and compounded versions of tirzepatide, the active ingredient in Lilly’s diabetes treatment Mounjaro and weight-loss treatment Zepbound.
IU Health’s new downtown hospital about 25% complete and on schedule, officials say
Officials with IU Health gave what they called a “summer update” on Wednesday and sounded optimistic about the project, one of the most expensive in Indiana history.
Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs
At issue is whether a drug developed by Point Biopharma, based in Indianapolis, infringed on a patent issued in 2020 and assigned to Purdue Research Foundation.
Ascension St. Vincent says it has restored electronic records system hit by May cyberattack
Ascension, the largest Catholic health system in the United States, was hit May 8 by a cyberattack that hindered computer access across the system and affected patient care.
IU Health to eliminate noncompete clauses for primary-care docs
The move comes a year after the Indiana General Assembly passed a law banning noncompete clauses in new contracts for physicians practicing primary care. IU Health said it decided to extend the same benefit to physicians who are currently employed.
Butler University lands $2.5M gift to support new two-year college
The gift, announced Tuesday morning, is from Indianapolis philanthropist and Butler University alumna Marianne Glick and her spouse, Mike Woods.
Lilly hopes for positive FDA news on Alzheimer’s drug as stock sets new high
Lilly officials have said they are “incredibly confident” in the drug’s potential and the fact that it “offers very meaningful benefits to people with early symptomatic Alzheimer’s disease.”